The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of ß-Thalassemia.
Int J Mol Sci
; 22(2)2021 Jan 16.
Article
in En
| MEDLINE
| ID: mdl-33467196
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Oxazoles
/
Pyridines
/
Benzimidazoles
/
Beta-Thalassemia
/
Erythropoiesis
Language:
En
Journal:
Int J Mol Sci
Year:
2021
Type:
Article
Affiliation country:
Switzerland